Venetoclax + Bendamustine–Rituximab or Venetoclax + Bendamustine–Obinutuzumab in CLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Haematologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Venetoclax Plus Bendamustine–Rituximab or Bendamustine–Obinutuzumab in Chronic Lymphocytic Leukemia: Final Results of a Phase 1b Study (GO28440)
Haematologica 2020 Oct 29;[EPub Ahead of Print], S Stilgenbauer, F Morschhauser, CM Wendtner, G Cartron, M Hallek, B Eichhorst, MF Kozloff, T Giever, G Lozanski, Y Jiang, H Huang, DS Pignataro, W Schary, K Humphrey, M Mobasher, G SallesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.